Herb-antitumour drug interaction risks: retrospective integrative oncology study
The risk for interactions between herbal products and anticancer drugs is difficult to predict, with online search engines providing limited and inconsistent information. Clinical implications of herb-antitumor drug interactions need to be better understood, enabling patients and their oncology healthcare providers to make informed decisions regarding their care.
Authors
- Noah Samuels (ORCID: https://orcid.org/0000-0002-1122-9607)
- Eran Ben‐Arye (ORCID: https://orcid.org/0000-0002-4058-3672)
- Shir Shapira
Institutions
- Technion – Israel Institute of Technology (IL)
- Hebrew University of Jerusalem (IL)
- Shaare Zedek Medical Center (IL)
- Haifa Medical Center (IL)
Publication Details
- Journal
- BMJ Supportive & Palliative Care
- Published
- 2024-08-13
- DOI
- https://doi.org/10.1136/spcare-2024-005098
- Citations
- 1
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 0.47